ASP Isotopes
ASP Isotopes Inc is an American advanced materials company developing isotope enrichment technologies for nuclear energy and healthcare applications. The company utilizes its proprietary Aerodynamic Separation Process to enrich isotopes including Silicon-28, Carbon-14, Molybdenum-100, and enriched Uranium. Revenue is primarily generated through research contracts, isotope supply agreements, and development capital raised ahead of commercial-scale production. Core end markets encompass advanced nuclear reactor developers, quantum computing hardware firms, radiopharmaceutical producers, and medical diagnostic laboratories globally. ASP Isotopes holds an innovative position in the materials industry as a developer of aerodynamic isotope enrichment technology. The company is headquartered in Washington, D.C., and its common stock trades on the Nasdaq Global Market.
2 of the funds FundTelligence covers report a position in ASP Isotopes.
- Legal name
- ASP Isotopes Inc
- Sector
- Materials
- Country
- United States
- Funds holding it
- 2
Funds holding ASP Isotopes
- BNP Clean Energy Solutions — BNP Paribas · 0.39 % (full portfolio disclosed, December 2025)
- DNB Fund Disruptive Opportunities — DNB · 0.16 % (full portfolio disclosed, September 2026)